Title: RESEARCH COMMUNICATIONS OF THE 28th ECVIM-CA CONGRESS Document date: 2018_12_19
ID: r79h9yzz_9
Snippet: This prospective study was conducted, with owner compliance, in the same referral centre between July 2016 and February 2018. Cats were included if they had a final diagnosis of LGAL or IBD. Haematoxylin and Eosin staining and immunohistochemistry using CD3, BLA36, MAC387 and MIBâ€1 (Ki67) antibodies were carried out on fullâ€thickness intestinal biopsies. Markers expressions in lamina propria and intraâ€epithelial lymphocytes (IEL) were asses.....
Document: This prospective study was conducted, with owner compliance, in the same referral centre between July 2016 and February 2018. Cats were included if they had a final diagnosis of LGAL or IBD. Haematoxylin and Eosin staining and immunohistochemistry using CD3, BLA36, MAC387 and MIBâ€1 (Ki67) antibodies were carried out on fullâ€thickness intestinal biopsies. Markers expressions in lamina propria and intraâ€epithelial lymphocytes (IEL) were assessed separately and quantified using a semiâ€quantitative scale. Blinded reading was performed by two boardâ€certified veterinary pathologists and one pathologist specialised in human digestive lowâ€grade proliferative disorders. All samples were subjected to clonality testing, based on PCR targeting of the CDR3 region of Tâ€cell receptor gamma for Tâ€cells (TCRγ).
Search related documents:
Co phrase search for related documents- marker expression and prospective study: 1, 2, 3, 4, 5
- owner compliance and prospective study: 1
- PCR targeting and prospective study: 1, 2, 3
- prospective study and receptor gamma: 1
- prospective study and referral centre: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
- prospective study and scale quantify: 1, 2
- receptor gamma and TCRγ receptor gamma: 1
Co phrase search for related documents, hyperlinks ordered by date